Complement effectors generated during activation contribute to various mechanisms that limit tumor growth

Complement effectors generated during activation contribute to various mechanisms that limit tumor growth. The complement system can be activated through several distinctive pathways. The classical pathway is initiated when C1q binds to its various targets. The lectin pathway begins with the binding of mannose-binding lectin (MBL) or ficolins to pathogen associated molecular patterns (PAMPs) or apoptotic host cells. This binding activates MBL-associated serine proteases (MASPs). Finally, the alternative pathway is initiated by low-grade cleavage of C3 in plasma and the generation of small amounts of C3b. The C3b cleavage product iC3b binds to tumor cells and through the interaction with complement receptor 3 (CD11b/CD18) on mononuclear phagocytes and natural killer (NK) cells enhances antibody-dependent cellular cytotoxicity (ADCC). C5a inhibits growth of tumors in a mammary sarcoma model in mice. The terminal complement complex (TCC) is thought to contribute to complement-dependent cytotoxicity (CDC), which is one of the mechanisms for eliminating tumor cells by therapeutic antibodies. C3a, which contributes to the mobilization of hematopoietic progenitor cells, probably contributes to tumor immune surveillance. Unbroken lines connect complement proteins to functions which inhibit tumor growth, whereas broken lines connect complement proteins to functions that can currently only be hypothetically linked to inhibition of tumor growth.
Complement effectors generated during activation contribute to various mechanisms that limit tumor growth

Publication

Is complement good or bad for cancer patients? A new perspective on an old dilemma. () Maciej M. Markiewski, et al. Trends Immunol. ;30(6):286-292. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates СзьсЗьвь C3 ncbigene_symbol C3 718
Homo sapiens Primates C4a C4A ncbigene_symbol C4A 720
Homo sapiens Primates C5a C5A ncbigene_synonym C5 727
Homo sapiens Primates C5a C5A ncbigene_synonym C5AR1 728
Homo sapiens Primates MASP1 MASP1 ncbigene_symbol MASP1 5648
Homo sapiens Primates MASP2 MASP2 ncbigene_symbol MASP2 10747
Homo sapiens Primates MBL MBL ncbigene_synonym MBL2 4153
Homo sapiens Primates MBL MBL ncbigene_synonym MBL3P 50639
Homo sapiens Primates C2 C2 ncbigene_symbol C2 717
Homo sapiens Primates C4b C4B ncbigene_symbol C4B 721
Danio rerio Vertebrates C4 C4 ncbigene_symbol c4 566261
Danio rerio Vertebrates C5 C5 ncbigene_symbol c5 565774
Danio rerio Vertebrates MASP1 MASP1 ncbigene_symbol masp1 100002060
Danio rerio Vertebrates MASP2 MASP2 ncbigene_symbol masp2 560277
Danio rerio Vertebrates MBL MBL ncbigene_synonym hbl1 100007982
Danio rerio Vertebrates MBL MBL ncbigene_synonym mbl2 100008009
Danio rerio Vertebrates C4b C4B ncbigene_symbol c4b 794635
Danio rerio Vertebrates lectin LECTIN ncbigene_symbol lectin 560034

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID